Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, April 8, 2016

3 emerging innovations for blood vessel repair

We need this for our migrating neurons to the damaged area, neuronal stem cells, neuroregeneration and neurogenesis. But I almost guarantee this will not be followed up, because we have NO leadership and NO strategy.

http://medcitynews.com/2016/04/various-innovative-blood-vessel-repair-options-continue-to-emerge/?

By Nicole Oran

Different new technologies continue to emerge with the hope of improving blood vessel repair and replacement for those with various diseases, either with the help of stem cells, 3D printing or the use of other human cells to develop actual new tissue. One disease in particular is peripheral arterial disease.
New technology created by Cellular Dynamics International has licensed its development to Indiana University, which creates new human blood vessels for patients with peripheral arterial disease (a narrowing of arteries that leads to restricted blood flow, usually in a person’s legs). Potential clients have already been chosen to utilize the technology. This kind of method could help to prevent the need for amputation.
The method was developed by Dr. Mervin Yoder, a researcher at Indiana University. According to United Press International, the method involves using “induced pluripotent stem cells from patients and turning them into cells with the characteristics of endothelial colony-forming cells found in umbilical cord blood — which form blood vessels and restore blood flow to to damaged tissue.”
Other innovation has previously been present in this particular area.
Back in 2013, a Duke University spinoff, Humacyte, made advancements in tissue engineering as it transplanted the first bioengineered blood vessel into the arm of a patient with end-stage kidney disease. It’s a product that’s derived from human cells but doesn’t have any of the biological properties that cause organ rejection. The vessels are created by cultivating donated human cells on a tubular scaffold.
Then there is 3D printing. As it was reported at the end of last year, researchers at Lawrence Livermore National Laboratory are using a 3D printer and a “bio-ink” made of materials compatible with the human body to print structures with living cells and biomaterials. The material and environment are engineered to enable small blood vessels, human capillaries, to develop on their own.